Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sutton

Showing results (251-260 of 290) with videos related to

Pageof 29
Sort By:
Cell|December 10, 2020
Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus InfectionLauren E Williamson, Theron Gilliland, Pramod K Yadav, et al.
Annals of Surgical Oncology|October 28, 2005
Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinomaJ Marc Pipas, Richard J Barth, Bassem Zaki, et al.
The Journal of Clinical Investigation|December 1, 2025
A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active siteTy A Sornberger, Rachael M Wolters, Iuliia M Gilchuk, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 24, 2015
The Cockayne Syndrome Natural History (CoSyNH) study: clinical findings in 102 individuals and recommendations for careBrian T Wilson, Zornitza Stark, Ruth E Sutton, et al.
Cell|October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodiesPavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
Plos Medicine|April 12, 2022
Patient-level interventions to reduce alcohol-related harms in low- and middle-income countries: A systematic review and meta-summaryCatherine A Staton, João Ricardo Nickenig Vissoci, Deena El-Gabri, et al.
Cell|March 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinNaveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Journal of Oncology Practice|March 2, 2011
Effect of initiating a multidisciplinary care clinic on access and time to treatment in patients with pancreatic adenocarcinomaTimothy B Gardner, Richard J Barth, Bassem I Zaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2012
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinomaJ M Pipas, B I Zaki, M M McGowan, et al.
Pageof 29

Showing results (251-260 of 290) with videos related to

Sort By:
Pageof 29
Cell|December 10, 2020
Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus InfectionLauren E Williamson, Theron Gilliland, Pramod K Yadav, et al.
Annals of Surgical Oncology|October 28, 2005
Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinomaJ Marc Pipas, Richard J Barth, Bassem Zaki, et al.
The Journal of Clinical Investigation|December 1, 2025
A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active siteTy A Sornberger, Rachael M Wolters, Iuliia M Gilchuk, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 24, 2015
The Cockayne Syndrome Natural History (CoSyNH) study: clinical findings in 102 individuals and recommendations for careBrian T Wilson, Zornitza Stark, Ruth E Sutton, et al.
Cell|October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodiesPavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
Plos Medicine|April 12, 2022
Patient-level interventions to reduce alcohol-related harms in low- and middle-income countries: A systematic review and meta-summaryCatherine A Staton, João Ricardo Nickenig Vissoci, Deena El-Gabri, et al.
Cell|March 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinNaveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Journal of Oncology Practice|March 2, 2011
Effect of initiating a multidisciplinary care clinic on access and time to treatment in patients with pancreatic adenocarcinomaTimothy B Gardner, Richard J Barth, Bassem I Zaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2012
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinomaJ M Pipas, B I Zaki, M M McGowan, et al.
Pageof 29